[ad_1] Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to…
medications
-
-
STOCK MARKET
Eli Lilly’s stock leaps toward a record as a 16% jump in prices boosted profit
by userby user[ad_1] Shares of Eli Lilly and Co. rallied toward yet another record close on Tuesday,…
-
STOCK MARKET
Novartis to bolster its oncology portfolio with acquisition of MorphoSys
by userby user[ad_1] Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys…
-
STOCK MARKET
GSK to buy asthma drug developer for up to $1.4 billion in pipeline push
by userby user[ad_1] GSK on Tuesday said it had struck a deal to acquire asthma drug developer…
-
STOCK MARKET
Eli Lilly launches home delivery of obesity drug Zepbound, warns on cosmetic use
by userby user[ad_1] Eli Lilly & Co. on Thursday announced the launch of new digital health services…
-
STOCK MARKET
4 things the best diets of 2024 have in common — and where Ozempic and Wegovy fit in
by userby user[ad_1] Losing weight is one of the top New Year’s resolutions that people make year…
-
[ad_1] Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities…
-
[ad_1] Moderna Inc.’s stock soared 10% Tuesday to lead S&P 500 index gainers, after Oppenheimer…
-
STOCK MARKET
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
by userby user[ad_1] French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development…
-
STOCK MARKET
Panbela Therapeutics’ stock soars on positive FDA news on child cancer treatment
by userby user[ad_1] Shares of Panbela Therapeutics Inc. skyrocketed again Tuesday, following positive news from the U.S.…